Garrett, N., Reddy, T., Yende-Zuma, N., Takalani, A., Woeber, K., Bodenstein, A., Jonas, P., Engelbrecht, I., Jassat, W., Moultrie, H. and Bradshaw, D., 2024. Safety, effectiveness and immunogenicity of heterologous mRNA-1273 boost after prime with Ad26. COV2. S among healthcare workers in South Africa: The single-arm, open-label, phase 3 SHERPA study. PLOS Global Public Health, 4(12), p.e0003260.
Safety, effectiveness and immunogenicity of heterologous mRNA-1273 boost after prime with Ad26.COV2.S among healthcare workers in South Africa: The single-arm, open-label, phase 3 SHERPA study.
- Journal Articles
